Stryker Seeks Exemption For Patient-Transport Devices
Executive Summary
A petition submitted to the US FDA seeks to exempt class II powered patient-transport devices from premarket notification requirements.
You may also be interested in...
Stryker Fails To Convince FDA To Exempt Patient-Transport Devices
The US agency didn’t buy Stryker’s argument in its April petition that there is no data suggesting patient-transport devices have a history of false and misleading claims.
Novel VR Treatment For Mental Illness Gets FDA Breakthrough
The US FDA has granted its breakthrough designation to a virtual reality therapy that recreates everyday scenarios for patients dealing with severe anxiety and schizophrenia.
Biden’s Biomedical Research Initiative Moves One Step Closer To Fruition
The US House of Representatives overwhelmingly passed legislation authorizing the creation of a federal health agency to advance biomedical research. The bill now goes to the Senate.